Hurwitz AA - Search Results

1

Prostate cancer: advances in immunotherapy.

Hurwitz AA, Yanover P, Markowitz M, Allison JP, Kwon ED. Hurwitz AA, et al. BioDrugs. 2003;17(2):131-8. doi: 10.2165/00063030-200317020-00005. BioDrugs. 2003. PMID: 12641491 Review.

2

Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM, Burg MB, Allison JP. Hurwitz AA, et al. Cancer Res. 2000 May 1;60(9):2444-8. Cancer Res. 2000. PMID: 10811122

3

Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.

Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Hurwitz AA, et al. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3013-7. doi: 10.1073/pnas.042684699. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867713 Free PMC article.

4

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP. Kwon ED, et al. Among authors: hurwitz aa. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8099-103. doi: 10.1073/pnas.94.15.8099. Proc Natl Acad Sci U S A. 1997. PMID: 9223321 Free PMC article.

5

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

Kwon ED, Foster BA, Hurwitz AA, Madias C, Allison JP, Greenberg NM, Burg MB. Kwon ED, et al. Among authors: hurwitz aa. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15074-9. doi: 10.1073/pnas.96.26.15074. Proc Natl Acad Sci U S A. 1999. PMID: 10611340 Free PMC article.

6

Costimulatory wars: the tumor menace.

Hurwitz AA, Kwon ED, van Elsas A. Hurwitz AA, et al. Curr Opin Immunol. 2000 Oct;12(5):589-96. doi: 10.1016/s0952-7915(00)00147-3. Curr Opin Immunol. 2000. PMID: 11007364 Review.

7

The TRAMP mouse as a model for prostate cancer.

Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED. Hurwitz AA, et al. Curr Protoc Immunol. 2001 Nov;Chapter 20:20.5.1-20.5.23. doi: 10.1002/0471142735.im2005s45. Curr Protoc Immunol. 2001. PMID: 18432778

8

Augmentation of T cell levels and responses induced by androgen deprivation.

Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED. Roden AC, et al. Among authors: hurwitz aa. J Immunol. 2004 Nov 15;173(10):6098-108. doi: 10.4049/jimmunol.173.10.6098. J Immunol. 2004. PMID: 15528346

9

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.

van Elsas A, Hurwitz AA, Allison JP. van Elsas A, et al. Among authors: hurwitz aa. J Exp Med. 1999 Aug 2;190(3):355-66. doi: 10.1084/jem.190.3.355. J Exp Med. 1999. PMID: 10430624 Free PMC article.

10

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Hurwitz AA, Yu TF, Leach DR, Allison JP. Hurwitz AA, et al. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10067-71. doi: 10.1073/pnas.95.17.10067. Proc Natl Acad Sci U S A. 1998. PMID: 9707601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page